Meloxicam Patent Expiration
Meloxicam was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Meloxicam Patents
Given below is the list of patents protecting Meloxicam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Anjeso | US10463673 | Nanoparticulate meloxicam formulations |
Feb 24, 2024
(Expired) | Baudax |
| Anjeso | US10471067 | Nanoparticulate meloxicam formulations |
Feb 24, 2024
(Expired) | Baudax |
| Anjeso | US10709713 | Nanoparticulate meloxicam formulations | May 26, 2030 | Baudax |
| Anjeso | US10881663 | Method of treating pain in elderly patients with mild renal impairment | Mar 08, 2039 | Baudax |
| Anjeso | US11253478 | Reduction of flake-like aggregation in nanoparticulate active agent compositions | May 26, 2030 | Baudax |
| Anjeso | US11458145 | Methods of administering intravenous meloxicam in a bolus dose | Mar 08, 2039 | Baudax |
| Anjeso | US8512727 | Nanoparticulate meloxicam formulations |
Dec 25, 2022
(Expired) | Baudax |
| Anjeso | US9974746 | Reduction of flake-like aggregation in nanoparticulate active agent compositions | May 26, 2030 | Baudax |
| Meloxicam | US6184220 | Oral suspension of pharmaceutical substance |
Mar 25, 2019
(Expired) | Avondale Pharms |
| Meloxicam |
US6184220 (Pediatric) | Oral suspension of pharmaceutical substance |
Sep 25, 2019
(Expired) | Avondale Pharms |
| Qmiiz Odt | US8545879 | Fast disintegrating compositions of meloxicam | Aug 31, 2030 | Tersera |
| Vivlodex | US9526734 | Formulation of meloxicam | Mar 31, 2033 | Iceutica Operations |
| Vivlodex | US9649318 | Formulation of meloxicam | Mar 31, 2035 | Iceutica Operations |
| Vivlodex | US9808468 | Formulation of meloxicam | Mar 31, 2035 | Iceutica Operations |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Meloxicam's patents.
Latest Legal Activities on Meloxicam's Patents
Given below is the list recent legal activities going on the following patents of Meloxicam.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 May, 2021 | US9808468 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8545879 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 16 Nov, 2020 | US9649318 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 16 Oct, 2020 | US9649318 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 29 Jun, 2020 | US9526734 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 22 May, 2020 | US9526734 |
| Patent Issue Date Used in PTA Calculation | 07 Nov, 2017 | US9808468 |
| Recordation of Patent Grant Mailed | 07 Nov, 2017 | US9808468 |
| Email Notification | 19 Oct, 2017 | US9808468 |
| Issue Notification Mailed | 18 Oct, 2017 | US9808468 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Meloxicam Generics
Several generic applications have been filed for Meloxicam. The first generic version for Meloxicam was by Roxane Laboratories Inc and was approved on Jul 19, 2006. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Jun 7, 2023.
Given below is the list of companies who have filed for Meloxicam generic.
1. TARO
Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Nov 7, 2006 |
| 7.5MG | tablet | Prescription | ORAL | AB | Nov 7, 2006 |
2. ANDA REPOSITORY
Anda Repository Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Anda Repository.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
3. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | May 13, 2009 |
| 7.5MG | tablet | Prescription | ORAL | AB | May 13, 2009 |
4. ZYDUS PHARMS USA
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG
(reference standard) | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
5. UNICHEM
Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Dec 20, 2006 |
| 7.5MG | tablet | Prescription | ORAL | AB | Dec 20, 2006 |
6. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Oct 2, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Oct 2, 2006 |
7. PURACAP PHARM
Puracap Pharmaceutical Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Puracap Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
8. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
9. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
10. YABAO PHARM
Yabao Pharmaceutical Co Ltd Beijing has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yabao Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
11. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | capsule | Prescription | ORAL | AB | Jun 1, 2020 |
| 10MG
(reference standard) | capsule | Prescription | ORAL | AB | Jun 1, 2020 |
12. LUPIN PHARMS
Lupin Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
13. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
14. ROXANE
Roxane Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
15. COREPHARMA
Corepharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Corepharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Jul 20, 2006 |
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 20, 2006 |
16. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Jun 7, 2023 |
| 7.5MG | tablet | Prescription | ORAL | AB | Jun 7, 2023 |
17. YUNG SHIN PHARM
Yung Shin Pharmaceutical Industrial Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yung Shin Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Dec 7, 2006 |
| 7.5MG | tablet | Prescription | ORAL | AB | Dec 7, 2006 |
18. IMPAX LABS INC
Impax Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 19, 2006 |
19. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
20. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
| 5MG | capsule | Prescription | ORAL | AB | Mar 9, 2021 |
21. AIPING PHARM INC
Aiping Pharmaceutical Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 19, 2006 |
22. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 20, 2006 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 20, 2006 |
23. CR DOUBLE CRANE
China Resources Double Crane Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cr Double Crane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Discontinued | ORAL | N/A | Dec 14, 2006 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Dec 14, 2006 |
24. DR REDDYS LABS INC
Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Jul 25, 2006 |
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 25, 2006 |